Core Scientific is trading 4.2% down now at $19.88 as investors digest its highly volatile reaction to blockbuster Q2 results and a major AMD partnership announced on July 28, 2026.
- Despite reporting strong revenue growth and raising full-year guidance, the stock is facing pressure from profit-taking following an initial post-earnings rally.
- Broader weakness across the technology and cryptocurrency sectors is further weighing on shares as the market reacts to the recent updates.